United States · Bill · HR
H.R. 2666 (118th)
Medicaid VBPs for Patients Act
Introduced
18 April 2023
Last action
—
Status
Placed on the Union Calendar, Calendar No. 768.
Sponsors
—
Subjects
Discovery layer
Source updated
27 May 2025
Summary
Medicaid VBPs for Patients Act or the MVP Act This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. ( Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.) The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes. Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to establish a program under which state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements. The bill's changes terminate five years after enactment; any value-based purchasing arrangements that are in effect as of the date of termination continue to apply.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Reported in House (text)
Reported in House (text)
Reported in House · EN · 19 December 2024
Reported in House (PDF)
Reported in House · EN · 19 December 2024
Introduced in House (text)
Introduced in House · EN · 18 April 2023
Introduced in House (PDF)
Introduced in House · EN · 18 April 2023
Introduced in House
summary · EN · 18 April 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/2666
- Open data entity: https://api.congress.gov/v3/bill/118/hr/2666